Artiva Biotherapeutics ARTV
NASDAQ ARTV
$6.83 +0.04 (+0.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Artiva Biotherapeutics (ARTV) Price to Book (2024 - 2026)

Updated

Artiva Biotherapeutics' Price to Book was 1.10 in Q2 2026, up 344.6% from 0.25 a year earlier but down 39.3% from the prior quarter.

Analysis

Artiva Biotherapeutics (ARTV) Price to Book (2024 - 2026) Analysis & Trends

For FY2025, Price to Book at Artiva Biotherapeutics came in at 0.96, up 58.6% from FY2024.

  • In earlier years, Price to Book was 0.61 in FY2024.
  • Quarterly Price to Book has moved between 0.25 (Q2 2025) and 1.81 (Q1 2026) over five years.
  • Compared with a year earlier, Price to Book has increased for three straight quarters, with growth averaging 164.8% over the last four quarters.
  • Per Business Quant data, ARTV's Price to Book in the three quarters before Q2 2026 was 1.81 (Q1 2026), 0.96 (Q4 2025) and 0.55 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Artiva Biotherapeutics 267.62 Mn 267.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.10
Mar 31, 2026 1.81
Dec 31, 2025 0.96
Sep 30, 2025 0.55
Jun 30, 2025 0.25
Mar 31, 2025 0.43
Dec 31, 2024 0.61
Sep 30, 2024 1.45
API Access

Artiva Biotherapeutics Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=ARTV&period=max&api_key=YOUR_API_KEY